Expression of high amounts of the CD117 molecule in a case of B‐cell non‐Hodgkin's lymphoma carrying the t(14:18) translocation
暂无分享,去创建一个
A. Órfão | J. Almeida | L. Escribano | C. Cámara | C. Bellas | P. Bravo | R. G. Sanz | Beatriz Díaz Agustín | David González | Isabel Fernández Fuertes
[1] A. Órfão,et al. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. , 1998, Leukemia & lymphoma.
[2] A. Órfão,et al. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). , 1998, Blood.
[3] S. Nishikawa,et al. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse. , 1998, Experimental hematology.
[4] P. Musto,et al. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. , 1998, Haematologica.
[5] J. S. San Miguel,et al. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype. , 1998, Haematologica.
[6] A. Órfão,et al. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. , 1998, Haematologica.
[7] H. Rodewald,et al. Interactions between c-kit and stem cell factor are not required for B-cell development in vivo. , 1997, Blood.
[8] A. Órfão,et al. Expression of the CD117 antigen (C‐Kit) on normal and myelomatous plasma cells , 1996, British journal of haematology.
[9] L. Stempora,et al. CD117/CD34 expression in leukemic blasts. , 1996, American journal of clinical pathology.
[10] K. Nakase,et al. Biological characteristics of CD7(+) acute leukemia. , 1996, Leukemia & lymphoma.
[11] D. Catovsky,et al. C-kit receptor (CD117) expression in acute leukemia. , 1996 .
[12] K. Welte,et al. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. , 1995, Blood.
[13] A. Órfão,et al. Immunophenotype of c‐kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML , 1995, British journal of haematology.
[14] Y. Miura,et al. Expression of c-kit receptor (CD117) and CD34 in leukemic cells. , 1995, Leukemia & lymphoma.
[15] B. Haynes,et al. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes. , 1994, Experimental hematology.
[16] M. Harada,et al. The c-kit molecule and the surface immunophenotype of human acute leukemia. , 1994, Leukemia & lymphoma.
[17] S. Nishikawa,et al. c-kit expression by B cell precursors in mouse bone marrow. Stimulation of B cell genesis by in vivo treatment with anti-c-kit antibody. , 1994, Journal of immunology.
[18] M. Reuss-Borst,et al. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. , 1994, Leukemia.
[19] V. Zagonel,et al. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. , 1994, Blood.
[20] M. Caligiuri,et al. Expression of a functional c-kit receptor on a subset of natural killer cells , 1993, The Journal of experimental medicine.
[21] H. Kitayama,et al. Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. , 1993, Leukemia & lymphoma.
[22] M. Fukumoto,et al. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. , 1992, Leukemia.
[23] A. Ullrich,et al. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. , 1991, Leukemia.
[24] S. Nishikawa,et al. Expression and function of c-kit in hemopoietic progenitor cells , 1991, The Journal of experimental medicine.
[25] J. V. van Dongen,et al. Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[26] M. Minden,et al. The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. , 1989, Leukemia.
[27] F. Ruddle,et al. Primary structure of c‐kit: relationship with the CSF‐1/PDGF receptor kinase family–oncogenic activation of v‐kit involves deletion of extracellular domain and C terminus. , 1988, The EMBO journal.
[28] A. Ullrich,et al. Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.
[29] L. Ashman,et al. A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. , 1985, Leukemia research.